BCL2 and metabolic disease: The requirement for dual death pathway inhibition (targeting both BCL-2 family proteins and lipid peroxidation) to preserve NSC pools underscores the complexity of dietary neurotoxicity and highlights the need for temporally stratified interventions in metabolic disorders.